Why Oregon's Attorney General Election May Be Referendum on Medical Marijuana With National Consequences
Why Oregon's Attorney General Election May Be Referendum on Medical Marijuana With National ConsequencesOregon’s Democratic primary for state attorney general May 15 was widely
viewed as a referendum on medical marijuana—and medical marijuana won.
Ellen Rosenblum, a former state appeals court judge who promised to
“make marijuana enforcement a low priority, and protect the rights of
medical-marijuana patients,” won 65 percent of the vote. She defeated
Dwight Holton, a former federal prosecutor who was backed by almost all
the state’s prosecutors and sheriffs and its two leading newspapers.
Holton had called Oregon’s medical-marijuana law a “trainwreck,” that
was “putting marijuana in the hands of people—in the hands of kids—that
are not using it for pain-management purposes.”
If elected—as is likely, because the Republicans are running only a
write-in candidate—Rosenblum would become Oregon’s first woman attorney
general. Medical-marijuana and legalization advocates contributed at
least one-fourth of her $600,000 campaign budget. She also billed
herself as the "Oregon candidate.” Holton, from a prominent political
family in Virginia, moved to Oregon in 2004.
“The medical-marijuana community here in Oregon was the swing vote,”
says Lori Duckworth, executive director of the Southern Oregon chapter
of the National Organization for Reform of Marijuana Laws and the
Cannabis Community Center in Medford. Holton, she says, “spoke very
loudly” when he endorsed federal raids on medical-marijuana growers in
southwest Oregon last fall.
“Ellen gave us hope,” says Madeline Martinez, head of Oregon NORML and
the World Famous Cannabis Café in Portland. Holton, in contrast, “sent
me a letter telling me to close my café because I give medicine away.”
“The medical-marijuana community has shown they’re a powerful voting
bloc,” says Kris Hermes of Americans for Safe Access in Oakland,
California. He points to California’s 2010 election for state attorney
general, in which Democrat Kamala Harris narrowly defeated Republican
Steve Cooley, who as Los Angeles prosecutor threatened to raid
medical-marijuana dispensaries even if the city licensed them. Harris,
he says, has publicly opposed federal raids on dispensaries.
“I definitely think it has national impact,” says Jill Harris, managing
director of strategic initiatives at the Drug Policy Alliance in New
York, whose political-action arm contributed to Rosenblum. “We hope that
U.S. Attorneys will think twice before they adopt these hardball
tactics against providers who are complying with state law. Elected
officials need to recognize that they’re behind the public on this
issue.”
A Mason-Dixon poll of “likely” 2012 voters conducted May 10-14 found
overwhelming opposition to enforcing federal laws against medical
marijuana in states that have legalized it. Overall, the respondents
opposed it by a 74-15 margin, with the percentages among demographic
subgroups ranging from more than 60 percent among Republicans and people
over 65 to more than 80 percent of people under 35 and African
Americans.
Others are more skeptical that the Oregon results will have a broad
national effect. “It certainly does alert elected officials that they
ignore the pro-marijuana vote at their own peril,” says Keith Stroup,
legal counsel at NORML’s national office in Washington. “But we don’t
want to get too far ahead of ourselves and presume we can do the same
thing in every other state.” In the Oregon race, he points out, there
was a clear choice on the issue—one not available in most other races,
such as this year’s presidential election.
Marijuana smokers and medical users are also much more organized on the
West Coast. In Oregon, which has slightly more than 2 million registered
voters, there are more than 55,000 patients and 28,000 caregivers
registered with the state’s medical-marijuana program. Combined with
their families, they represent a significant bloc, Martinez contends.
That bloc is much less cohesive in the Northeast. Still, New Jersey is
slowly implementing its 2010 medical marijuana law, Connecticut’s
legislature in early May passed a bill that would let pharmacists
dispense medical marijuana, and in New York, the state assembly’s health
committee approved a bill to legalize medical marijuana on May 15.
“I don’t think one race across the country will affect what happens
here,” says a staffer for New York Assemblymember Richard Gottfried, a
Manhattan Democrat who is the health committee’s chair and the bill’s
lead sponsor. “But we really have a lot of support here, and people
understand the importance of medical marijuana.”
In a Siena College poll of New York registered voters taken in early
May, the respondents supported legalizing medical marijuana by a 57-33
margin.
The Oregon vote shows that “public opinion and support for this issue
grows and continues to grow,” says New York state senator Diane Savino, a
Staten Island Democrat who is sponsoring the bill in the upper house.
People in New York may not have followed the Oregon results, but they
have similar concerns. The issue, she says, affects “every family that
has ever been touched by a terminal illness or a debilitating disease.”
If “there’s a treatment out there that would help, why would we
prosecute a doctor?”
The New York law would allow patients to use marijuana if a physician
certifies that they have a “serious,” “debilitating,” or
“life-threatening” condition for which it would help. For example,
migraine headaches would qualify if a doctor believes they’re severe
enough. Some people take OxyContin for migraines, Savino notes, and
“OxyContin is far more dangerous than medical marijuana.”
The patient would then have to be certified by the state Department of
Health, which would also license growers at secure indoor sites. In
general, already licensed pharmacies and hospitals would dispense
medical marijuana. Patients would be allowed to grow their own only if
traveling to a dispensary was too difficult.
Previous medical marijuana measures have failed in New York’s
legislature, which is gerrymandered so the Democrats control the
assembly and the Republicans the state senate—with the result that most
major legislation is settled by “three men in a room,” Governor Andrew
Cuomo and the leaders of both houses. Still, Savino is optimistic. No
senators, she says, have told her outright that they won’t vote for the
bill, and “not one person” has contacted her to say they oppose it.
Cuomo said in April that there were “tremendous risks” in legalizing
medical marijuana and that the legislature probably wouldn’t have time
to handle the issue before its session ends in June.
“I would be wildly optimistic if I thought we could do it by June 21,”
Savino responds. But Cuomo saying “‘there isn’t enough time” is
different from him saying “no,” she adds.
Overcoming Federal Hurdles
Federal law, which declares that marijuana has no valid medical use and
makes cultivation and sale felonies, remains a huge obstacle to any
state efforts to enable a legal supply of medical marijuana. In
February, Delaware Gov. Jack Markell suspended the state’s fledgling
medical-marijuana program after the federal government threatened to
prosecute state employees involved in licensing. Washington Gov.
Christine Gregoire vetoed a licensing bill last year for similar
reasons.
The Obama administration has said that it is going after marijuana
traffickers, not individual patients, but Hermes calls that
hypocritical. “He’s directly impacting their lives by cutting off their
supply. He can’t have that double standard.”
New Jersey, on the other hand, has not had any problems with federal
authorities, says Roseanne Scotti, head of the state’s Drug Policy
Alliance chapter. “We didn’t get any clarification, but we didn’t get
any threats,” she says.
She believes this is partly because Gov. Chris Christie, a former
federal prosecutor, is savvy about Justice Department procedures and
policies, and partly because the state’s law, enacted in 2010, is the
country’s most restrictive. It limits medical marijuana to a handful of
specific illnesses. Cancer patients qualify only if they have severe or
chronic pain, severe nausea, wasting syndrome, or less than a year to
live.
The state is moving forward on implementing the law. A dispensary in
Montclair, one of six permitted in the state, has just gotten local
approval and a license to start growing. More than 100 doctors have
registered for the program, and patient registration will begin later
this year. Still, the delay has been “very difficult for patients,” says
Scotti.
Oregon’s law, enacted by a 1998 initiative, occupies a middle ground
between New Jersey’s restrictiveness and states like California and
Colorado, where dispensaries are widespread. It does not permit
dispensaries, and voters rejected an initiative to allow them in 2010.
Instead, it authorizes caregivers to grow six plants each for up to four
patients.
However, a number of dispensaries have been operating, mostly in the
Portland area, as private “members-only” clubs. Open only to registered
patients, they take donations in exchange for medical marijuana. Such
spaces create a community life for patients, both Martinez and Duckworth
say.
The Cannabis Community Center, opened in 2009, also provides a food and
clothing bank and help with energy-assistance programs, says Duckworth, a
former certified medication administrator who also managed an
assisted-living home. The Oregon law allows growers to be reimbursed for
their expenses, she says, so the group collects receipts from them and
then determines how much that comes to per gram.
“’Donation’ is not an acceptable word,” she says. “The law says ‘reimbursement.’”
State legislators would like to work with Washington, says Stroup, but
“it’s not clear exactly what the federal government will or will not
allow.” The Obama administration has mainly gone after the larger
dispensaries and growers with more than 100 plants, but, “we’re in a bit
of a gray market now. Until we get that federal law changed, we’re
always going to run up against those limits, and we’re not sure where
those limits are.”
Savino doesn’t have a specific answer as to how New York would handle
the conflict with federal law. “We hope that the federal government will
change their approach. It’s so absurd,” she says. “At some point, the
federal government will realize they’re handling this issue
incorrectly—just like rights for the LGBT community.”
Martinez says she’ll vote for Obama again, but criticizes him for
prosecuting medical growers and dispensaries and not going after Wall
Street bankers and brokers for fraud. Citibank CEO Jamie Dimon, she
says, just lost more than $2 billion on dubious speculation, but “he’s
not going to do any time. Somebody who’s growing marijuana might get 99
years.”